Business
Investor Online Q&A
Investor Online Q&A.
About this update from Nuformix Plc
[{"type":"text","content":"\n\nREACH\n \n2 June 2023\n \nNuformix plc\n \n(\"Nuformix\" or the \"Company\" or the \"Group\")\n \nInvestor Online Q&A\n \nNuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, is pleased to announce that the Company's Executive Director, Dr Dan Gooding, will be hosting an online Q&A session at 5.30 p.m. GMT on Tuesday 13 June 2023. This session is open to all existing and prospective shareholders. Those who wish to attend should register via the following link where they will be provided with access details:\n \nhttps://us02web.zoom.us/webinar/register/WN_fV_2UztcQLSl1S1tC4vTGg\n \nParticipants will have the opportunity to submit questions during the session, but questions are welcomed in advance and may be submitted to: [email protected]\n \nEnquiries:\n \n\n\n\nNuformix plc\n\n\n \n\n\n\n\nDr Dan Gooding, Executive Director\n \n\n\nVia IFC Advisory\n \n\n\n\n\nStanford Capital Partners Limited\n\n\n \n\n\n\n\nTom Price / Patrick Claridge (Corporate Finance)\n\n\n+44 (0) 20 3650 3650\n\n\n\n\nJohn Howes / Bob Pountney (Corporate Broking)\n\n\n+44 (0) 20 3650 3652\n \n\n\n\n\nIFC Advisory Limited\n\n\n \n\n\n\n\nTim Metcalfe\nZach Cohen\n\n\n+44 (0) 20 3934 6630\[email protected]\n\n\n\n \nAbout Nuformix\n \nNuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. The Company aims to use its expertise in discovering, developing and patenting novel drug forms, with improved physical properties, to develop new products in new indications that are, importantly, differentiated from the original (by way of dosage, delivery route or presentation), thus creating new and attractive commercial opportunities. Nuformix has a pipeline of pre-clinical assets with potential for significant value and early licensing opportunities.\n \n\n","length":5558,"tagName":"div"}]